Healthcare
Wednesday, May 4, 2016
BRIEF-Eisai says European Commission approves Halaven for treatment of advanced Liposarcoma in Europe
* European commission approves halaven (eribulin) for
treatment of advanced liposarcoma in europe
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment